Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tecentriq
Pharma
Vabysmo soars as Roche grows through COVID sales declines
Vabysmo grew its market share since August despite Regeneron winning an FDA go-ahead for its high-dose Eylea, according to Swiss drugmaker Roche.
Angus Liu
Feb 1, 2024 11:36am
Exelixis joins Novartis on FDA waiting list in prostate cancer
Jan 25, 2024 8:00am
BMS's subcutaneous Opdivo measures up to infused version
Oct 19, 2023 11:10am
BMS joins AZ, Merck with positive NSCLC trial around surgery
Sep 22, 2023 11:15am
Roche hits FDA delay with subcutaneous Tecentriq
Sep 7, 2023 2:46pm
Roche, Exelixis combo triumphs in prostate cancer trial
Aug 21, 2023 9:57am